top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Anticancer Properties of Natural and Derivative Products
Anticancer Properties of Natural and Derivative Products
Autore Lupiáñez José Antonio
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (312 p.)
Soggetto topico Research & information: general
Soggetto non controllato total phenolic content
total flavonoid content
GC-MS
DPPH
antioxidant
anticancer agent
anti-inflammatory agent
gingival fibroblasts
oral cancer
natural extract
Adenosma bracteosum
extract
anti-cancer
cell line
isolated compounds
caspase-3
bioactive compounds
metabolites
wine
grapes
breast cancer
chemoprevention
chemotherapy
squamous cell carcinoma
Moringa oleifera
3-hydroxy-β-ionone
antioxidant activity
antioxidant enzymes
anti-proliferative activity
maslinic acid
melanoma
Olea europaea L.
ROS levels
photodynamic therapy
cancer
photosensitiser
natural compounds
Elaeagnus angustifolia
EMT
apoptosis
AKT/PI3K signaling pathway
human hepatocarcinoma HepG2 cells
migration activity
proliferation
oxidative stress
ROS level
uvaol
lung metastases
in vivo
complementary medicine
medicinal mushrooms
triterpenoic acid
tormentic acid
betulinic acid
oleanolic acid
rhodamine B
cytotoxicity
hepatocellular carcinoma (HCC)
Pogostemon cablin (PPa extract)
cell cycle
synergism
natural photosensitive compounds
anticancer activity
hypericin
emodin
quinizarin
danthron
interaction
DNA
glioblastoma (GBM)
lactucopicrin (LCTP)
temozolomide (TMZ)
autophagy
NF-κB
p62/SQSM1
natural product
therapeutic triglyceride
xenograft study
Caveolin-1
actin cytoskeleton
betulin glycoconjugates
click chemistry
1,3-dipolar cycloaddition
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557370303321
Lupiáñez José Antonio  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Circulating Tumor Cells: Finding Rare Events for A Huge Knowledge of Cancer Dissemination
Circulating Tumor Cells: Finding Rare Events for A Huge Knowledge of Cancer Dissemination
Autore Alix-Panabieres Catherine
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (366 p.)
Soggetto non controllato FOLFIRINOX
immunofluorescence imaging
AR-V7
circulating tumour cells
chemoradioresistance
CTC-based treatment decisions
rVAR2
immunophenotyping
immune system
CellSearch®
flow cytometry
clinical trials
circulating tumor DNA
synaptophysin
stem cells
colorectal cancer
melanoma
CTC biology
platelets
AR
CTC capture technology
castration resistant prostate cancer (CRPC)
PD-L1 expression
rovalpituzumab tesirine
HMB-45
thymidylate synthase
ctDNA
tumor cell dissemination
solid cancers
metastasis
locally advanced rectal cancer
miRNA
epithelial-to-mesenchymal transition (EMT)
NSCLC
tumor biomarkers
tumor stem cells
circulating tumor cells
major histocompatibility complex class I (MHCI)
bone marrow
heterogeneity
cerebrospinal liquid biopsy
fish
glioma
in vivo flow cytometry
colorectal surgery
CellSearch
single-cell analysis
disseminated tumor cells
EasyCount slides
microsatellite instability
circulating plasma cells
circulating leukemia cells
ARV7
SLUG
androgen receptor
metastatic colorectal cancer
leukocyte-derived extracellular vesicles
prostate cancer (PCa)
neutrophils
liquid biopsy
enzalutamide
CD133
enrichment and detection technologies
biomarkers
immune checkpoint inhibitors
biomarker
RAD23B
microbiome
integrin B1
ACCEPT
emboli
small-cell lung carcinoma
EPISPOT
microfluidics
early breast cancer
circulating tumor cells (CTC)
tumor-initiating cells (TICs)
immunomodulation
xenograft models
CTC-derived xenografts
malaria
circulating tumor cells (CTCs)
clinical utility
exosomes
liquid surgery
ctRNA
CTCs
epithelial-mesenchymal transition
targeted therapy
hematological cells
gene expression analysis
hepatocellular carcinoma (HCC)
breast cancer
EpCAM enrichment
prostate cancer
CTC
abiraterone
fibronectin
CTC-derived ex vivo models
CTMat
chromogranin A
CTM
exosome
ISBN 3-03928-699-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Circulating Tumor Cells
Record Nr. UNINA-9910404091403321
Alix-Panabieres Catherine  
MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Links between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges: Mechanistic and Therapeutic Challenges
Links between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges: Mechanistic and Therapeutic Challenges
Autore Gabazza Esteban C
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (348 p.)
Soggetto non controllato bleomycin
regeneration
antitumor efficacy
lung cancer
SOX2
leiomyosarcoma
lung cancer (LC)
nanoparticles
cytokines
hepatocellular carcinoma
metabolic reprogramming
hepatic stellate cells
angiogenesis
transforming growth factor-?
anaplastic lymphoma kinase
idiopathic pulmonary fibrosis
growth factor
pathogenesis
cancer-associated fibroblasts
fibrosis
lipopolysaccharide
DHA
lncRNA
SREBP-1
YAP
protein S
non-small cell lung cancer (NSCLC)
omega-3 fatty acid
inflammation
metastasis
clinical symptoms
miRNA
smooth muscle tumor of uncertain malignant potential
Wnt
interstitial fluid pressure
heterogeneity
hepatocytes
myometrium
tumor necrosis factor ?
tumor
tumor microenvironment
extracellular matrix
TAZ
carcinogenesis
cystic formation
pulmonary fibrosis
HBV
cytokine
genetic instability
diagnosis
EMT
crizotinib
Hippo pathway
GPR120
marker
HCV
non-alcoholic steatohepatitis
pathology
common pathways
apoptosis
type I collagen
GPR40
acute lung injury
uterine fibroid
renal injury
pathophysiology
reactive oxygen species
immunohistochemistry
SMAD
butylidenephthalide
leiomyoma
cirrhosis
Erk1/2
targeted therapy
TGF-?
mechanotransduction
therapy
breast cancer
hepatocellular carcinoma (HCC)
hepatic stellate cells (HSCs)
idiopathic pulmonary fibrosis (IPF)
cancer-associated fibroblasts (CAFs)
cancer
signal pathway
tumor stiffness
ISBN 3-03921-707-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Links between Fibrogenesis and Cancer
Record Nr. UNINA-9910367745903321
Gabazza Esteban C  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Targeting STAT3 and STAT5 in Cancer
Targeting STAT3 and STAT5 in Cancer
Autore Moriggl Richard
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (578 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato multiple myeloma
STAT3
S3I-1757
nanoparticle
CD38
siRNA/RNAi
polyethylenimine
PEI
lipopolyplex
siRNA delivery
glioma
glioblastoma
STAT5
AKT
ERK1/2
prolactin
androgens
prostate cancer
knockout
escape mechanisms
stem/progenitor cells
cell hierarchy
cancer
CD4+ T cells
CD8+ T cells
myeloid cells
immune check point
hepatitis C virus (HCV)
cirrhosis
hepatocellular carcinoma (HCC)
endoplasmic reticulum (ER) stress
oxidative stress (OS)
unfolded protein response (UPR)
microRNA-122 (miR-122)
nuclear factor erythroid 2-related factor 2 (NRF2)
signal transducer and activator of transcription 3 (STAT3)
hepatocyte nuclear factor 4 alpha (HNF4A)
solid cancers
cell cycle
apoptosis
inflammation
mitochondria
stemness
tumor suppression
melanoma
autoimmune disease
immunotherapy
tumor-immune cell interactions
breast cancer
PD-L1
M2 macrophages
NK cells
STAT3 inhibitor XIII
hedging
transaction costs
dynamic programming
risk management
post-decision state variable
cancer progression
cancer-stem cell
cytokine
therapy resistance
metastasis
immunosuppression
tumor microenvironment
proliferation
tyrosine kinase 2
JAK family of protein tyrosine kinases
signal transducer and activator of transcription
cytokine receptor signaling
gain-of-function mutation
tumorigenesis
ADAM17
interleukin-6
trans-signaling
epidermal growth factor receptor (EGF-R)
shedding
metalloprotease
tumor necrosis factor alpha (TNFα)
inflammation associated cancer
colon cancer
lung cancer
SH2 domain
mutations
autosomal-dominant hyper IgE syndrome
inflammatory hepatocellular adenomas
T-cell large granular lymphocytic leukemia
T-cell prolymphocytic leukemia
growth hormone insensitivity syndrome
nuclear pore complex
nuclear transport receptors
nucleocytoplasmic shuttling
targeting
tumor-associated macrophages
adoptive T cell therapy
immune suppression
STAT transcription factors
JAK
STAT
T-PLL
T-cell leukemia
meta-analysis
STAT5B signaling
small-molecule inhibitors
cancer models
companion animals
comparative oncology
pharmacological inhibitor
STAT5 signaling
chemotherapy resistance
myeloid leukemia
heat shock proteins
chaperones
stabilization
targeted therapy
ovarian cancer
hematopoietic cancers
therapeutic targeting
pharmacological inhibitors
mTOR
Bone Marrow Failure Syndromes
lymphocytes
lymphoma
T-cells
RHOA
NGS
MPN
JAK2 V617F
neoplastic stem cells
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557623503321
Moriggl Richard  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui